Reify Health Exit Candidate
π¦ Potential exit path:
SPAC, IPO

Select partners: SubjectWell.
Funding π°
Total $259.6M
Select investors Coatue Management, Battery Ventures, Sierra Ventures, Adams Street Partners, ICONIQ Growth
Key people π§βπ€βπ§
- Ralph Passarella - Co-Founder & CEO
- Michael Lin - Co-Founder & Executive Chairman
- Mukul Goyal - VP Of Engineering
- Kent Siri - VP of Marketing
- Joshua Brandoff - Head of Data
Highlights β
- The company is solving real pain point(s) in clinical trials and makes them more efficient
- StudyTeam is used by top-20 global biopharma companies such as Amgen, AstraZeneca, and Eli Lilly and Company, and approximately 4,000 research sites across 65 countries.
- Reify Health will help transform clinical trials, starting with the critical pain point of patient recruitment and reinventing trial operations around it - Aaron Weiner, Coatue Management π
- Similar companies: Science 37
Last update: September 6, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more